Practical use of sleep EEG for objective assessment and diagnosis of major depression - Multicenter exploratory prospective study - - SEEDs Study 2

Shiga University of Medical Science0 sites183 target enrollmentStarted: April 3, 2017Last updated: October 17, 2023

Conditions

Trial Snapshot

183 cases registered. There were 176 cases analyzed.

•1) Organic brain disorders identified in the brain structural imaging including CT and MRI (taken within past 6 months). 2) Epileptic disorders. 3) Somatic disorders that may cause depressive symptoms such as hypothyroidism, Cushing disease, or SLE. 4) Neurotic disorders that may cause depressive symptoms such as Parkinson disease, Huntington disease, or multiple sclerosis. 5) Sleep apnea syndrome. 6) Disorderly sleep-wake pattern such as graveyard shift or shift-workers. 7) Pathological suicidal ideations and/or suicide attempts. 8) Past episodes of substance use disorder. 9) Addiction to illegal drugs (amphetamine, morphine, cocaine, cannabis, phencyclidine) by Triage test. 10) Prescribed central nervous stimulating drugs, opioid medications (Ritalin, Concerta, and opioids), Modafinil, steroids, and/or interferon. 11) Taking part in and will be going to take part in the other clinical trials during the study period. 12) Ruled unfit to the study participation by the principal investigator or a member of the research project.

Sponsor